CSL Vifor

This sponsor has funded 3 studies across 28 countries.

PAS funded by this sponsor.
EU PAS ID Status RMP requirement Title Protocol uploaded Results uploaded
25192 Finalised Not included in RMP Severe hypersensitivity reactions associated with high dose iv iron containing medicinal products No Yes
27963 Finalised Not included in RMP Severe hypersensitivity reactions associated with i.v. iron containing medicinal products in countries of the European Economic Area – before and... No Yes
43542 Ongoing Not included in RMP Comparison of outcomes in patients undergoing major planned surgeries before vs. after the implementation of Patient Blood Management (PBM): a... No No

PAS by Risk Management Plan (RMP) requirement

CSL Vifor

The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.

Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.